A Clinical Trial of Immuno-bridging Between Different Manufacture Scales of Recombinant COVID-19 Vaccine (Sf9 Cell)
Clinical trial NCT05465785 · COMPLETED
Trial details
- NCT number
- NCT05465785
- Sponsor
- WestVac Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-20
- Primary completion
- 2023-03-11
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.